The American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson's Research, and the Parkinson's Foundation finalized their recommendations following a recent National Institutes of Health inquiry. Their proposal centers on six core objectives to be achieved by 2035, ranging from reducing the financial burden on affected families to accelerating clinical research into the disease's underlying biological and environmental triggers.
Advocacy groups set 2035 goals for National Parkinson's Plan
Three major Parkinson's organizations have submitted a unified blueprint to federal regulators, aiming to shape the nation's first comprehensive strategy against the disease. As the Advisory Council on Parkinson's Research, Care, and Services convenes, these groups are pushing for aggressive benchmarks to address environmental risks, research, and patient financial security.
Representatives from the organizations emphasized that the plan must translate into tangible improvements for the 1.2 million Americans currently living with Parkinson's and atypical parkinsonisms. Their strategy calls for a more robust integration of patient-centered care within federally funded programs like Medicare and Medicaid, alongside a systemic effort to mitigate exposure to toxins such as paraquat. By prioritizing these specific outcomes, the coalition seeks to ensure that the final federal framework reflects the lived experiences of patients, their families, and their care partners.
Comments (0)
No comments yet. Be the first!